Gerard E Plante

Title: Gerard E Plante: Innovator in B-Bradykinin Receptor Antagonists

Introduction

Gerard E Plante is a notable inventor based in Sherbrooke, Canada. He has made significant contributions to the field of pharmacology, particularly in the development of antagonists for the B-bradykinin receptor. His work addresses critical health issues associated with inflammation and diabetes.

Latest Patents

Gerard E Plante holds a patent related to novel antagonists to the B-bradykinin (B-BK) receptor. This invention demonstrates good affinity and selectivity for the receptor, with some compounds showing resistance to enzymatic degradation. The synthesis of B-receptors is induced during inflammation, which is a significant factor in various medical conditions. His research confirms the presence of B-BK receptors in diabetic animal models and spontaneously hypertensive rats. The B-BK antagonists developed by Plante have shown the ability to abolish vasocontraction induced by B-BK and reduce glycemia in diabetic animals to normal levels. This innovation is particularly useful for treating conditions where B-receptor expression is linked to diabetic vasculopathy and other related symptoms.

Career Highlights

Gerard E Plante is affiliated with the Université De Sherbrooke, where he continues to advance his research in pharmacology and receptor antagonism. His work has implications for treating various inflammatory conditions and improving the quality of life for individuals suffering from diabetes.

Collaborations

Gerard has collaborated with notable colleagues, including Domenico Recoli and Witold A Neugebauer. Their combined expertise has contributed to the advancement of research in the field of receptor antagonists.

Conclusion

Gerard E Plante's innovative work in developing B-bradykinin receptor antagonists represents a significant advancement in medical research. His contributions have the potential to improve treatment options for patients suffering from inflammation and diabetes.